InspireMD Logo.png
InspireMD to Present at the H.C. Wainwright 20th Annual Global Investment Conference in New York City
04 sept. 2018 07h30 HE | InspireMD, Inc.
TEL AVIV, ISRAEL, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...
jounce.png
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
29 août 2018 08h00 HE | Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
28 août 2018 08h00 HE | VBI Vaccines, Inc.
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
galectin.jpg
Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
02 avr. 2018 10h20 HE | Galectin Therapeutics Inc.
NORCROSS, Ga., April 02, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that...